Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 18
  • Journal CiteScore: 5.91
  • Journal Impact Factor: 4.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page


Academic websites containing H1N1 swine flu information need to provide content on therapeutic options including vaccines and neuraminidase-inhibitors for pregnant women: Time for a Policy Statement on web site content

Alison Jane Murray , Craig Steven McLachlan

We retrospectively reviewed 21 National Australian University academic websites for swine flu guidelines for pregnancy and therapeutic measures. This study was conducted at the height of the swine flu epidemic in Australia, August 2009. No detailed information on the use and safety of neuraminidase-inhibitors, across population sub-groups were identified within the content pages of Australian University Websites. Further concern was an absence of information on which antiviral and vaccination treatments are appropriate for pregnant women and breastfeeding mothers. Pregnant women are at high risk of developing severe illness and related complications with the onset of swine flu. It is thus important that pregnant women have access to adequate web site information and updated information advising on appropriate use of anti-viral neuraminidase-inhibiting drugs and treatment, vaccination and options for associated fever and information that they represent a high risk subgroup.  This mini-commentary provides useful information and a relevant web link ( for inclusion on academic websites to inform pregnant women on effective therapeutic information that can be communicated via university and health web sites even after a swine flu pandemic.